These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36427600)

  • 1. One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.
    Kaiser JE; Turok DK; Gero A; Gawron LM; Simmons RG; Sanders JN
    Am J Obstet Gynecol; 2023 Apr; 228(4):438.e1-438.e10. PubMed ID: 36427600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
    Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
    Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
    Kaplan J; Turok DK; Gero A; Kaiser JE; Simmons RG; Fay KE
    Contraception; 2023 Feb; 118():109893. PubMed ID: 36240903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study.
    Phillips SJ; Hofler LG; Modest AM; Harvey LFB; Wu LH; Hacker MR
    Am J Obstet Gynecol; 2017 Jul; 217(1):57.e1-57.e6. PubMed ID: 28315664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
    Sanders JN; Turok DK; Gawron LM; Law A; Wen L; Lynen R
    Am J Obstet Gynecol; 2017 Jun; 216(6):590.e1-590.e8. PubMed ID: 28188772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
    Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
    Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of emergency contraception options over 1 year.
    Bellows BK; Tak CR; Sanders JN; Turok DK; Schwarz EB
    Am J Obstet Gynecol; 2018 May; 218(5):508.e1-508.e9. PubMed ID: 29409847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year continuation of reversible contraception.
    Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
    Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
    Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
    Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Krashin J; Tang JH; Mody S; Lopez LM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
    Todd CS; Jones HE; Langwenya N; Hoover DR; Chen PL; Petro G; Myer L
    PLoS Med; 2020 May; 17(5):e1003110. PubMed ID: 32442189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
    Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
    Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial.
    Turok DK; Leeman L; Sanders JN; Thaxton L; Eggebroten JL; Yonke N; Bullock H; Singh R; Gawron LM; Espey E
    Am J Obstet Gynecol; 2017 Dec; 217(6):665.e1-665.e8. PubMed ID: 28842126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.